The Cooper Companies Inc (COO) Q2 2025 Earnings Report

For Q2 2025, The Cooper Companies Inc reported robust financial results highlighted by a consolidated revenue of $1.002 billion, up 6% year-over-year and a strong operational performance across both of its segments, CooperVision and CooperSurgical. Organic revenue growth was particularly impressive, standing at 7%, indicative of the company's growth strategy and market share gains. CooperVision's revenue reached $670 million, growing 5% overall, while CooperSurgical increased to $333 million, up 8% organically. Management emphasized successful product launches in the competitive contact lens market and operational efficiencies that enhanced margins, despite facing a complex global environment. The company maintained a confident outlook with revised revenue guidance for the fiscal year, underscoring its strategic initiatives for future growth.